The Commission has presented a Communication for the proposed launch of a European bio-defence preparedness programme called “HERA Incubator” to address the emerging threat of coronavirus variants. Plans include important new research investments, mobilising an additional €30 million from Horizon 2020 to be complemented by a further €120 million from Horizon Europe. The new programme will provide the means to detect and counter further...

Experts from the European Union (EU) and the Association of Southeast Asian Nations (ASEAN) convened on 8 December 2020 to exchange best practices on policies and to identify further opportunities for collaboration on COVID-19 vaccines. As two leading regional organisations, the EU and ASEAN share a common interest in pursuing a multilateral approach to an affordable, fair and equitable access to safe and effective COVID-19 vaccines. The 23rd...

The European Commission is proposing an EU strategy to accelerate the development, manufacturing, and deployment of vaccines against COVID-19, where research and innovation can contribute greatly. The EU Strategy for COVID-19 vaccines lays down how the EU and Member States together will accelerate the development and manufacturing of vaccines against COVID-19. The strategy rests on two pillars: providing financial support to de-risk developers’...

This scheme supports teams of researchers working on human infection studies in low- and middle-income countries. The aim is to accelerate vaccine development. Career stage: Leading a research programme Where your host organisation is based: Low- or middle-income countries Type of researcher: Basic, Clinical Level of funding: £3 million to £5 million Duration of funding: Up to 5 years Who can apply You can apply for this award if you are part of...